LEADER 01318nam0-2200373---450- 001 990009453450403321 005 20120411201822.0 035 $a000945345 035 $aFED01000945345 035 $a(Aleph)000945345FED01 035 $a000945345 100 $a20111017d1962----km-y0itay50------ba 101 1 $aita 102 $aIT 200 1 $aSieri, vaccini, anatossine, tubercoline nelle profilassi e terapia delle malattie infettive$fH.J. Parish, D.A. Cannon$gpresentazione del prof. A. De Barbieri$gtraduzione e note del prof. E. Cuboni 205 $a5. ed. 210 $aMilano$cIstituto sieroterapico milanese S. Belfanti$d1962 215 $a347 p.$cfig., fot$d21 cm 454 0$12001$aAntisera, toxoids, vaccine and tubercolins in prophylaxis and treatment$913740 610 0 $aImmunoterapia 676 $a615.37 700 1$aParish,$bH. J.$g$0509269 701 1$aCannon,$bD. A.$g$0513551 702 1$aDe Barbieri,$bAugusto 702 1$aCuboni,$bEttore 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009453450403321 952 $aA VII 16/a$b1026$fDMVCM 952 $a43 F 8$bs.i.$fDMVAP 959 $aDMVAP 959 $aDMVCM 996 $aAntisera, toxoids, vaccine and tubercolins in prophylaxis and treatment$913740 997 $aUNINA